Global and United States Cerebrovascular Disease Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Carotid Endarterectomy
1.2.3 Carotid Angioplasty Or Carotid Artery Stenting
1.2.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.3 Market by Application
1.3.1 Global Cerebrovascular Disease Market Share by Application: 2020 VS 2026
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cerebrovascular Disease Market Perspective (2015-2026)
2.2 Global Cerebrovascular Disease Growth Trends by Regions
2.2.1 Cerebrovascular Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cerebrovascular Disease Historic Market Share by Regions (2015-2020)
2.2.3 Cerebrovascular Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cerebrovascular Disease Players by Market Size
3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2015-2020)
3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2015-2020)
3.2 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
3.4 Global Cerebrovascular Disease Market Concentration Ratio
3.4.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2019
3.5 Key Players Cerebrovascular Disease Area Served
3.6 Key Players Cerebrovascular Disease Product Solution and Service
3.7 Date of Enter into Cerebrovascular Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cerebrovascular Disease Breakdown Data by Type (2015-2026)
4.1 Global Cerebrovascular Disease Historic Market Size by Type (2015-2020)
4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2021-2026)
5 Cerebrovascular Disease Breakdown Data by Application (2015-2026)
5.1 Global Cerebrovascular Disease Historic Market Size by Application (2015-2020)
5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cerebrovascular Disease Market Size (2015-2026)
6.2 North America Cerebrovascular Disease Market Size by Type (2015-2020)
6.3 North America Cerebrovascular Disease Market Size by Application (2015-2020)
6.4 North America Cerebrovascular Disease Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Cerebrovascular Disease Market Size (2015-2026)
7.2 Europe Cerebrovascular Disease Market Size by Type (2015-2020)
7.3 Europe Cerebrovascular Disease Market Size by Application (2015-2020)
7.4 Europe Cerebrovascular Disease Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Cerebrovascular Disease Market Size (2015-2026)
8.2 China Cerebrovascular Disease Market Size by Type (2015-2020)
8.3 China Cerebrovascular Disease Market Size by Application (2015-2020)
8.4 China Cerebrovascular Disease Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Cerebrovascular Disease Market Size (2015-2026)
9.2 Japan Cerebrovascular Disease Market Size by Type (2015-2020)
9.3 Japan Cerebrovascular Disease Market Size by Application (2015-2020)
9.4 Japan Cerebrovascular Disease Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Cerebrovascular Disease Market Size (2015-2026)
10.2 Southeast Asia Cerebrovascular Disease Market Size by Type (2015-2020)
10.3 Southeast Asia Cerebrovascular Disease Market Size by Application (2015-2020)
10.4 Southeast Asia Cerebrovascular Disease Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
11.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2015-2020))
11.1.5 Johnson & Johnson Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Cerebrovascular Disease Introduction
11.2.4 Amgen Revenue in Cerebrovascular Disease Business (2015-2020)
11.2.5 Amgen Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
11.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2015-2020)
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
11.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2015-2020)
11.4.5 Sanofi-Aventis Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Cerebrovascular Disease Introduction
11.5.4 Merck Revenue in Cerebrovascular Disease Business (2015-2020)
11.5.5 Merck Recent Development
11.6 Sangamo BioSciences
11.6.1 Sangamo BioSciences Company Details
11.6.2 Sangamo BioSciences Business Overview
11.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
11.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2015-2020)
11.6.5 Sangamo BioSciences Recent Development
11.7 Aldagen
11.7.1 Aldagen Company Details
11.7.2 Aldagen Business Overview
11.7.3 Aldagen Cerebrovascular Disease Introduction
11.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2015-2020)
11.7.5 Aldagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Carotid Endarterectomy
Table 4. Key Players of Carotid Angioplasty Or Carotid Artery Stenting
Table 5. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Table 6. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Cerebrovascular Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Cerebrovascular Disease Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Cerebrovascular Disease Market Share by Regions (2015-2020)
Table 10. Global Cerebrovascular Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Cerebrovascular Disease Market Share by Regions (2021-2026)
Table 12. Cerebrovascular Disease Market Market Trends
Table 13. Cerebrovascular Disease Market Drivers
Table 14. Cerebrovascular Disease Market Challenges
Table 15. Cerebrovascular Disease Market Restraints
Table 16. Global Cerebrovascular Disease Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Cerebrovascular Disease Market Share by Players (2015-2020)
Table 18. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2019)
Table 19. Global Cerebrovascular Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cerebrovascular Disease Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Cerebrovascular Disease Market Size Share by Type (2015-2020)
Table 25. Global Cerebrovascular Disease Revenue Market Share by Type (2021-2026)
Table 26. Global Cerebrovascular Disease Market Size Share by Application (2015-2020)
Table 27. Global Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Cerebrovascular Disease Market Size Share by Application (2021-2026)
Table 29. North America Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Cerebrovascular Disease Market Share by Type (2015-2020)
Table 31. North America Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Cerebrovascular Disease Market Share by Application (2015-2020)
Table 33. North America Cerebrovascular Disease Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Cerebrovascular Disease Market Share by Country (2015-2020)
Table 35. Europe Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Cerebrovascular Disease Market Share by Type (2015-2020)
Table 37. Europe Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Cerebrovascular Disease Market Share by Application (2015-2020)
Table 39. Europe Cerebrovascular Disease Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Cerebrovascular Disease Market Share by Country (2015-2020)
Table 41. China Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 42. China Cerebrovascular Disease Market Share by Type (2015-2020)
Table 43. China Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 44. China Cerebrovascular Disease Market Share by Application (2015-2020)
Table 45. China Cerebrovascular Disease Market Size by Region (US$ Million) (2015-2020)
Table 46. China Cerebrovascular Disease Market Share by Region (2015-2020)
Table 47. Japan Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Cerebrovascular Disease Market Share by Type (2015-2020)
Table 49. Japan Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Cerebrovascular Disease Market Share by Application (2015-2020)
Table 51. Japan Cerebrovascular Disease Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Cerebrovascular Disease Market Share by Country (2015-2020)
Table 53. Southeast Asia Cerebrovascular Disease Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Cerebrovascular Disease Market Share by Type (2015-2020)
Table 55. Southeast Asia Cerebrovascular Disease Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Cerebrovascular Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Cerebrovascular Disease Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Cerebrovascular Disease Market Share by Country (2015-2020)
Table 59. Johnson & Johnson Company Details
Table 60. Johnson & Johnson Business Overview
Table 61. Johnson & Johnson Product
Table 62. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 63. Johnson & Johnson Recent Development
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Product
Table 67. Amgen Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 68. Amgen Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Product
Table 72. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Sanofi-Aventis Company Details
Table 75. Sanofi-Aventis Business Overview
Table 76. Sanofi-Aventis Product
Table 77. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 78. Sanofi-Aventis Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Product
Table 82. Merck Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 83. Merck Recent Development
Table 84. Sangamo BioSciences Company Details
Table 85. Sangamo BioSciences Business Overview
Table 86. Sangamo BioSciences Product
Table 87. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 88. Sangamo BioSciences Recent Development
Table 89. Aldagen Company Details
Table 90. Aldagen Business Overview
Table 91. Aldagen Product
Table 92. Aldagen Revenue in Cerebrovascular Disease Business (2015-2020) (US$ Million)
Table 93. Aldagen Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cerebrovascular Disease Market Share by Type: 2020 VS 2026
Figure 2. Carotid Endarterectomy Features
Figure 3. Carotid Angioplasty Or Carotid Artery Stenting Features
Figure 4. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features
Figure 5. Global Cerebrovascular Disease Market Share by Application: 2020 VS 2026
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Hospitals & Diagnostic Centers Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Cerebrovascular Disease Report Years Considered
Figure 12. Global Cerebrovascular Disease Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Cerebrovascular Disease Market Share by Regions: 2020 VS 2026
Figure 14. Global Cerebrovascular Disease Market Share by Regions (2021-2026)
Figure 15. Global Cerebrovascular Disease Market Share by Players in 2019
Figure 16. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2019
Figure 18. North America Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 46. Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 48. Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 49. Merck Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 50. Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 51. Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed